Fajri Gafar

Other Support Staff, Faculty of Science and Engineering, PharmacoTherapy, Epidemiology and Economics

https://orcid.org/0000-0002-0084-9018

Phone+31 50 363 2476
EmailF.Gafar@rug.nl

A Deusinglaan1, Gebouw 3214, ruimte 0450
9713 AV Groningen
Netherlands

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

4 Article
2 Meeting Abstract
1 Letter

Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review
Chimeh, R. A., Gafar, F., Pradipta, I. S., Akkerman, O. W., Hak, E., Alffenaar, J-W. C. & van Boven, J. F. M., 1-Aug-2020, In: International Journal of Tuberculosis and Lung Disease. 24, 8, p. 811-819 9 p.
Research output: Contribution to journal › Article › Academic › peer-review
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in The Netherlands
Gafar, F., Van't Boveneind-Vrubleuskaya, N., Akkerman, O. W., Wilffert, B. & Alffenaar, J-W. C., 2020, In: European Respiratory Journal. 54, 4, 12 p., 1901402.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

5 Citations (Scopus)

57 Downloads (Pure)
Towards elimination of childhood and adolescent tuberculosis in the Netherlands: An epidemiological time-series analysis of national surveillance data
Gafar, F., Ochi, T., Boveneind-Vrubleuskaya, van t', N., Akkerman, O. W., Erkens, C., van den Hof, S., van der Werf, T. S., Alffenaar, J-W. C. & Wilffert, B., 1-Oct-2020, In: European Respiratory Journal. 56, 4, 2001086.
Research output: Contribution to journal › Article › Academic › peer-review
Antituberculosis Drug-induced Liver Injury in Children: Incidence and Risk Factors During the Two-month Intensive Phase of Therapy
Gafar, F., Arifin, H., Jurnalis, Y. D., Yani, F. F., Fitria, N., Alffenaar, J-W. & Wilffert, B., Jan-2019, In: Pediatric infectious disease journal. 38, 1, p. 50-53 4 p.
Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)
Remarkable outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands, and factors associated with mortality and treatment default
Gafar, F., Boveneind-Vrubleuskaya, van 't, N., Akkerman, O., Wilffert, B. & Alffenaar, J-W., Nov-2019, In: International Journal of Tuberculosis and Lung Disease. 22, 11, p. S143 1 p.
Research output: Contribution to journal › Meeting Abstract › Academic

1 Supervision and examination of PhD students of the UG
1 Professional or public event

Epidemiology and treatment outcomes of childhood and adolescent tuberculosis in the Netherlands
Fajri Gafar (Speaker)
15-Jan-2021
Activity: Talk and presentation › Professional or public event › Professional
Personalised medicine in children with tuberculosis: Association of pharmacogenetics and pharmacokinetics of isoniazid with antituberculosis drug-induced liver injury.
Jasper Stevens (Co-supervisor)
4-Jan-2018 → …
Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic

Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review

Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in The Netherlands

Towards elimination of childhood and adolescent tuberculosis in the Netherlands: An epidemiological time-series analysis of national surveillance data

Antituberculosis Drug-induced Liver Injury in Children: Incidence and Risk Factors During the Two-month Intensive Phase of Therapy

Remarkable outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands, and factors associated with mortality and treatment default

Epidemiology and treatment outcomes of childhood and adolescent tuberculosis in the Netherlands

Personalised medicine in children with tuberculosis: Association of pharmacogenetics and pharmacokinetics of isoniazid with antituberculosis drug-induced liver injury.